These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 23200666)

  • 1. A novel derivative of riccardin D induces cell death through lysosomal rupture in vitro and inhibits tumor growth in vivo.
    Wang Y; Wang L; Hu Z; Ji Y; Lin Z; Yuan H; Ji M; Lou H
    Cancer Lett; 2013 Feb; 329(2):207-16. PubMed ID: 23200666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
    Xue X; Sun DF; Sun CC; Liu HP; Yue B; Zhao CR; Lou HX; Qu XJ
    Lung Cancer; 2012 Jun; 76(3):300-8. PubMed ID: 22261315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way.
    Yue B; Zhang YS; Xu HM; Zhao CR; Li YY; Qin YZ; Wang RQ; Sun D; Yuan Y; Lou HX; Qu XJ
    Cancer Lett; 2013 Jan; 328(1):104-13. PubMed ID: 22995069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of DNA damage and p21-dependent senescence by Riccardin D is a novel mechanism contributing to its growth suppression in prostate cancer cells in vitro and in vivo.
    Hu Z; Zhang D; Hao J; Tian K; Wang W; Lou H; Yuan H
    Cancer Chemother Pharmacol; 2014 Feb; 73(2):397-407. PubMed ID: 24322375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riccardin D induces cell death by activation of apoptosis and autophagy in osteosarcoma cells.
    Wang Y; Ji Y; Hu Z; Jiang H; Zhu F; Yuan H; Lou H
    Toxicol In Vitro; 2013 Sep; 27(6):1928-36. PubMed ID: 23810952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riccardin D-N induces lysosomal membrane permeabilization by inhibiting acid sphingomyelinase and interfering with sphingomyelin metabolism in vivo.
    Li L; Niu H; Sun B; Xiao Y; Li W; Yuan H; Lou H
    Toxicol Appl Pharmacol; 2016 Nov; 310():175-184. PubMed ID: 27660101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway.
    Tian HL; Yu T; Xu NN; Feng C; Zhou LY; Luo HW; Chang DC; Le XF; Luo KQ
    Cancer Lett; 2010 Nov; 297(1):18-30. PubMed ID: 20494511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma.
    Sun CC; Zhang YS; Xue X; Cheng YN; Liu HP; Zhao CR; Lou HX; Qu XJ
    Eur J Pharmacol; 2011 Sep; 667(1-3):136-43. PubMed ID: 21704029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bisphosphonate incadronate inhibits intraperitoneal dissemination in an in vivo pancreatic cancer model.
    Takiguchi S; Nishino Y; Inoue K; Ikeda M; Kataoka Y; Matsusue K; Nishiyama K; Iguchi H
    Oncol Rep; 2012 Jul; 28(1):111-6. PubMed ID: 22484715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
    Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
    Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress.
    Ostenfeld MS; Fehrenbacher N; Høyer-Hansen M; Thomsen C; Farkas T; Jäättelä M
    Cancer Res; 2005 Oct; 65(19):8975-83. PubMed ID: 16204071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: In vitro and in vivo studies.
    Yue B; Zhao CR; Xu HM; Li YY; Cheng YN; Ke HN; Yuan Y; Wang RQ; Shi YQ; Lou HX; Qu XJ
    Biochim Biophys Acta; 2013 Jan; 1830(1):2194-203. PubMed ID: 23085067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diallyl trisulfide induces apoptosis and inhibits proliferation of A549 cells in vitro and in vivo.
    Li W; Tian H; Li L; Li S; Yue W; Chen Z; Qi L; Hu W; Zhu Y; Hao B; Gao C; Si L; Gao F
    Acta Biochim Biophys Sin (Shanghai); 2012 Jul; 44(7):577-83. PubMed ID: 22595511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of polypeptides in bee venom on growth inhibition and apoptosis induction of the human hepatoma cell line SMMC-7721 in-vitro and Balb/c nude mice in-vivo.
    Hu H; Chen D; Li Y; Zhang X
    J Pharm Pharmacol; 2006 Jan; 58(1):83-9. PubMed ID: 16393467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the lysosome by an aminomethylated Riccardin D triggers DNA damage through cathepsin B-mediated degradation of BRCA1.
    Wang Y; Niu H; Hu Z; Zhu M; Wang L; Han L; Qian L; Tian K; Yuan H; Lou H
    J Cell Mol Med; 2019 Mar; 23(3):1798-1812. PubMed ID: 30565390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
    Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW
    Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo.
    Xu YZ; Zheng RL; Zhou Y; Peng F; Lin HJ; Bu Q; Mao YQ; Yu LT; Yang L; Yang SY; Zhao YL
    Cancer Lett; 2011 Dec; 313(1):44-53. PubMed ID: 21944661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of a novel recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand.
    Fang F; Wang AP; Yang SF
    Acta Pharmacol Sin; 2005 Nov; 26(11):1373-81. PubMed ID: 16225761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.